Computer engineers and radiologists at Duke University have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy, and it shows physicians exactly how it came to its conclusions.

A new infusion being offered by Duke HomeCare & Hospice. Certain patients who test positive for COVID-19 are eligible for an infusion designed to decrease the risk of transmission, stimulate a stronger immune response, decrease symptoms and make it less likely a recovery in the hospital will be necessary.

Fatima Syed, MD, assistant professor of medicine (General Internal Medicine), has been selected as the new Director of the Primary Care Leadership Track (PCLT) program in the School of Medicine. Syed has served as Associate Director since 2020.

Janice Massey, MD, Professor of Neurology and Senior Vice Chair of the Department of Neurology has been awarded the Lifetime Achievement Award by The American Association of Neuromuscular & Electrodiagnostic Medicine, (AANEM) in recognition of her decades of service to patient care and the field of neurology.

Provost Kornbluth and Dean Klotman discuss the biology of omicron and how Duke is adapting its policies.

Duke researchers have identified a genomic signature which makes it possible to develop a test to identify which men should undergo treatment early in their diagnosis, vs. those who could safely postpone therapy, if they need it at all.

Your taste buds may or may not be able to tell real sugar from a sugar substitute like Splenda, but there are cells in your intestines that can and do distinguish between the two sweet solutions. And they can communicate the difference to your brain in milliseconds.

Dr. L. Ebony Boulware, is the first-author on a perspective in New England Journal of Medicine (NEJM) published Saturday, entitled, Combating Structural Inequities — Diversity, Equity, and Inclusion in Clinical and Translational Research.

ALICE – Academic Leadership, Innovation, and Collaborative Engagement –  is year-long a leadership development opportunity for mid-career women faculty in the School of Medicine

The awards program supports promising, early career physician-scientists at Duke as they develop independent research programs. Each recipient will receive $75,000 annually for three years to support their research programs.